Matinas BioPharma (MTNB) has provided an update.
The Company has updated its corporate presentation for use at upcoming conferences and investor meetings. This essential information tool, key for anyone interested in the company’s performance and prospects, is designed to provide a comprehensive overview of the company’s activities and is not considered legally filed under relevant securities laws but is for informative purposes.
See more insights into MTNB stock on TipRanks’ Stock Analysis page.
